Table 1.
Overall (n = 67) |
Grade B or C PHLF |
P † | ||
---|---|---|---|---|
Yes (n = 8) | No (n = 59) | |||
Background data | ||||
Age (years)* | 71 (42–88) | 72 (59–81) | 71 (42–88) | 0·641‡ |
Sex ratio (M : F) | 40 : 27 | 7 : 1 | 33 : 26 | 0·087 |
BMI (kg/m2)* | 21·9 (15·0–30·7) | 19·5 (16·7–24·2) | 22·2 (15·0–30.7) | 0·012‡ |
Child–Pugh grade | 0·119 | |||
A | 66 (99) | 7 (88) | 59 (100) | |
B | 1 (1) | 1 (12) | 0 (0) | |
C | 0 (0) | 0 (0) | 0 (0) | |
Preoperative management | ||||
Portal vein embolization | 0·035 | |||
Yes | 19 (28) | 5 (63) | 14 (24) | |
No | 48 (72) | 3 (37) | 45 (76) | |
Biliary drainage | 0·093 | |||
Yes | 48 (72) | 8 (100) | 40 (68) | |
No | 19 (28) | 0 (0) | 19 (32) | |
Preoperative blood tests * | ||||
Total bilirubin (mg/dl) | 0·70 (0·21–2·15) | 0·91 (0·70–2·15) | 0·66 (0·21–1·92) | 0·003‡ |
AST (units/l) | 33 (9–99) | 29 (16–57) | 33 (9–99) | 0·529‡ |
ALT (units/l) | 45 (7–227) | 40 (17–227) | 45 (7–206) | 0·504‡ |
Albumin (g/dl) | 3·6 (2.8–4·6) | 3·4 (2·8–4·1) | 3·7 (2·8–4·6) | 0·089‡ |
Prothrombin time (%) | 90·2 (71·1–130·0) | 79·9 (75·6–92·2) | 90·6 (71·1–130·0) | 0·018‡ |
Platelet count (×104/μl) | 22·9 (8·4–48·6) | 26·7 (13·6–45·3) | 22·7 (8·4–48·6) | 0·219‡ |
ICGK* | 0·18 (0·10–0·28) | 0·15 (0·10–0·22) | 0·18 (0·12–0·28) | 0.020‡ |
ICGK-F* | 0·09 (0·04–0·16) | 0·06 (0·04–0·08) | 0·09 (0·06–0·16) | < 0·001‡ |
CT volumetry-related parameters | ||||
FLRV (ml)* | 514 (336–1208) | 379 (336–510) | 536 (353–1208) | < 0·001‡ |
FLR proportion (%)* | 35 (40–87) | 38 (37–50) | 52 (35–87) | 0·004‡ |
Values in parentheses are percentages unless indicated otherwise;
values are median (range). AST, aspartate aminotransferase; ALT, alanine aminotransferase; ICGK, plasma clearance rate of indocyanine green (ICG); ICGK-F, future liver remnant (FLR) plasma clearance rate of ICG; FLRV, FLR volume.
Continuous variables were compared using the Wilcoxon rank sum test, while categorical variables were compared using the χ2 test or Fisher’s exact test as appropriate.
Wilcoxon rank sum test.